Pricing Log in Create free account
Saturday 17 October 2026 Export BHST’s income statement to Excel — free account

BioHarvest Sciences Inc.

BHST Consumer Defensive Packaged Foods

BioHarvest Sciences Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.5 million, up 37.0% from fiscal 2024. In the quarter to June 2026, revenue grew 3.78%, EPS grew 29.2%, free cash flow fell 64.0% and total debt fell 73.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

1.85 0.15 +8.82%
Market cap
$38.5M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
0.33
Beneish M
−2.41
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 35.90%

Capital & Financial Ratios $m

Market Cap 38.54
Revenue 35.48
Net Income (11.07)
Free Cash Flow (10.75)
Net Debt (13.56)
Current Ratio 2.24 (at or above 1.5: strong)
Debt/Equity 0.13 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E —
P/S ratio 1.18
P/B ratio 2.12
Past 5Y EPS Growth —
This Y EPS Growth 12.08%
Next Y EPS Growth 36.49% (at or above 15%: strong)
Next Y revenue growth —
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.8×, against a ten-year median of 6.2×; over the ten years it ranged from −9.8× in 2020 to 434× in 2021.
P/S against its own 10 years 2.02%
10-year low 10-year high
P/B against its own 10 years 29.74%
10-year low 10-year high
EV/Sales against its own 10 years 2.41%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 5 2 23 16
Receivables 1 2 3 4
Inventory 2 4 5 6
Other — — — —
9 8 31 26
2023 2024 2025 Q'26
Payables 2 4 3 3
ST’ Debt 21 4 0 3
Other 1 1 0 0
26 14 8 12

Compound Annual Growth %

10y 5y 3y
Sales — 144.37% 84.46%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 9 9 — — —
’25 8 9 9 9 35
’24 5 6 7 7 25
’23 2 3 3 5 13
’22 1 1 2 2 5
’21 0 0 1 1 2
’20 0 0 0 0 0
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) (3) — — —
’25 (1) (1) (2) (2) (7)
’24 (2) (1) (2) (2) (7)
’23 (2) (3) (1) (3) (9)
’22 (3) (2) (2) (3) (9)
’21 (1) (2) (1) (2) (7)
’20 (1) 0 (2) (1) (4)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (3) — — —
’25 (2) (2) (3) (3) (10)
’24 (2) (3) (2) (3) (10)
’23 (2) (3) (1) (3) (10)
’22 (3) (2) (3) (3) (10)
’21 (1) (2) (2) (3) (8)
’20 (1) 0 (2) (1) (4)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.11) (0.17) — — —
’25 (0.13) (0.24) (0.14) (0.10) (0.60)
’24 (0.48) (0.04) (0.16) (0.17) (0.80)
’23 (0.06) (0.21) (0.13) (0.53) (1.05)
’22 (0.16) (0.18) (0.30) (0.21) (0.86)
’21 (0.56) 0.14 (0.25) (0.12) (0.79)
’20 (0.09) (0.13) (0.15) (0.30) (0.68)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — 0.08 0.05 0.18 5.85 4.03 4.66 4.72

Analyst estimates 2026–2028

Powerpack
High — — — 0.26 0.25 67.90 17.50 8.19 7.70 12.80
People
People Employees — — — — — — — — 87 89
Revenue/emp, $m — — — 0.00 0.00 0.00 0.00 0.00 0.29 0.39
Income, $m
Income, $m Revenue — — — 0 0 2 5 13 25 35
Gross margin, % — — — 13.30 34.85 31.87 22.17 44.45 55.35 59.34
EBT — — (5) (5) (7) (10) (11) (13) (13) (11)
EBT margin, % — — 0.00 (2,435.78) (1,662.63) (467.51) (204.37) (99.15) (51.23) (32.05)
Net income — — 0 (5) (7) (10) (11) (13) (13) (11)
Depreciation — — — 0 0 0 1 1 1 2
Per share, $
Per share, $ Revenue — — — 0.07 0.04 0.17 0.42 0.94 1.56 1.87
Earnings — — — (1.80) (0.68) (0.79) (0.86) (1.05) (0.80) (0.60)
Cash flow — — — (0.81) (0.40) (0.55) (0.71) (0.63) (0.41) (0.39)
Capex — — — (0.01) (0.02) (0.13) (0.10) (0.11) (0.18) (0.13)
Free cash flow — — — (0.82) (0.42) (0.68) (0.80) (0.74) (0.59) (0.52)
Book value — — 0.00 (9.13) (0.24) 0.23 (0.45) (1.10) 0.08 1.38
Shares, m — — — 3 10 12 13 14 16 18
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S — — — 0.00 4.42 74.69 17.23 5.98 3.97 2.77
P/B — — — 0.07 0.00 54.99 0.00 0.00 75.25 3.75
EV/Sales — — — 0.00 (0.07) 72.73 18.47 7.18 4.03 2.18
EV/FCF — — — 0.11 0.01 (18.13) (9.67) (9.10) (10.67) (7.84)
Cash, $m
Cash, $m Operating cash flow — — — (2) (4) (7) (9) (9) (7) (7)
Capex — — — 0 0 (2) (1) (1) (3) (2)
Free cash flow — — — (2) (4) (8) (10) (10) (10) (10)
Balance, $m
Balance, $m Working capital — — 1 (25) 0 3 (7) (17) (6) 23
Total debt — — — 23 — — 9 21 4 3
Net debt — — (1) 23 (2) (4) 7 15 2 (20)
Shareholders’ equity — — 4 (27) (2) 3 (6) (15) 1 25
Returns, %
Returns, % ROA — — 0.00 (138.88) (179.74) (126.70) (114.65) (103.00) (64.56) (30.65)
ROIC — — (85.46) 0.00 0.00 0.00 (750.28) (1,916.54) (153.54) (69.80)
ROE — — 0.00 45.67 45.00 (3,509.64) 731.03 120.91 190.98 (83.17)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

BioHarvest Sciences Inc. vs peers in Packaged Foods (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
BRID Bridgford Foods Corporation $52.2M — (loss-making) 2.5× −9.51% (below 0%: shrinking) n/m −616.62% (below 0%: shrinking) 23.10% (7.04%) Compare
BHST BioHarvest Sciences Inc. $38.5M — (loss-making) — +3.78% (above 0%: growing) n/m −64.01% (below 0%: shrinking) 57.51% (28.37%)
BOF BranchOut Food Inc. $35.8M — (loss-making) — +36.14% (above 0%: growing) n/m −39.88% (below 0%: shrinking) 2.17% (57.54%) Compare
LSF Laird Superfood, Inc. $30.3M — (loss-making) 15.5× +244.38% (above 0%: growing) n/m +149.69% (above 0%: growing) 30.31% (4.51%) Compare
JVA Coffee Holding Co., Inc. $26.0M 5.4× — (loss-making) −9.30% (below 0%: shrinking) n/m +126.65% (above 0%: growing) 25.01% 10.72% Compare
HAIN The Hain Celestial Group, Inc. $25.7M — (loss-making) — (loss-making) −27.60% (below 0%: shrinking) n/m +176.43% (above 0%: growing) 22.50% (21.16%) Compare
SRXH SRX Global Inc. $25.2M — (loss-making) 7.8× +26.90% (above 0%: growing) n/m −29.90% (below 0%: shrinking) 26.65% (94.37%) Compare
YGFGF YanGuFang International Group Co., Ltd. $23.5M — — — — — — — Compare
BRLS Borealis Foods Inc. $22.5M — (loss-making) — +7.63% (above 0%: growing) n/m +91.21% (above 0%: growing) 11.39% (27.97%) Compare
Median of peers $25.8M — 7.8× +7.63% — +91.21% 23.10% (21.16%)

All 71 Packaged Foods stocks →

BioHarvest Sciences Inc. (BHST) key facts

  • Strength: BioHarvest Sciences Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.5 million, up 37.0% from fiscal 2024.
  • BioHarvest Sciences Inc. (BHST) is a Packaged Foods company in the Consumer Defensive sector, listed on Nasdaq.
  • As of October 16, 2026, BHST traded at $1.85, a market capitalization of $38.5 million.
  • Return on equity was −83.2% and debt-to-equity 0.13.
  • Its Piotroski F-score is 4 out of 9 and its Altman Z-score is 0.33 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

BioHarvest Sciences Inc. (BHST) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/BHST · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com